Skip to main content
Log in

Synthesis of a New Series of 4-Aryl-1,4-Dihydropyridines with Calcium Channel Blocking and Vasodilatory Activity

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Several new amide derivatives of 4-aryl-1,4-dihydropyridine carboxylic congeners have been synthesized in this study to obtain therapeutically useful compounds. The changes in pharmacological properties of dihydropyridines by the presence of polar groups at different positions of 4-phenyl substituent and also by introduction of unsymmetrical ester groups in the synthesized symmetrical analogs have been studied. In vitro calcium channel blocking activity has been evaluated in cultures of neonatal rat cortical neurons by measuring the inhibitory response at L-type calcium channels activated by veratridine. The newly synthesized dihydropyridines displayed moderate calcium channel blockade with IC50 values ranging from 2 to 10 μM in comparison to nifedipine (IC50 = 57.7 nM). The vasodilatory activity was evaluated on isolated rat thoracic aortic rings precontracted by phenylephrine/KCl (30 mM). The symmetrically substituted dihydropyridine 8a exhibited maximum activity with IC50 = 0.64 μM but was found to be approximately 24 times less active in comparison to standard drug nifedipine with IC50 = 27.5 nM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Scheme 1
Scheme 2

Similar content being viewed by others

References

  • Carron R, Perez-Vizcaino F, Delphon E, Tamargo J (1991) Effects of propafenone on 45 Ca movements and contractile responses in vascular smooth muscle. Br J Pharmacol 103:1453–1457

    PubMed  CAS  Google Scholar 

  • Huber D, Ehrhardt JD, Decker N, Himber J, Andermann G, Leclerc G (1991) Synthesis and ocular antihypertensive activity of new imidazolidine derivatives containing a beta-blocking side chain. J Med Chem 34:3197–3204

    Article  PubMed  CAS  Google Scholar 

  • Iwanami M, Shibanuma T, Fujimoto M, Kawai R, Tamazawa K, Takenaka T, Takahashi K, Murakami M (1979) Synthesis of new water-soluble dihydropyridine vasodilators. Chem Pharm Bull 27:1426–1440

    Article  PubMed  CAS  Google Scholar 

  • Jain P, Naran G, Jindal DP, Bansal R, Calle C, Carron R, Pemberton K, Harvey AL (2006) Synthesis of a new series of 4-aryl-1,4-dihydropyridines with calcium channel blocking and vasodilatory activity. Pharmazie 61:400–405

    PubMed  CAS  Google Scholar 

  • Janis RA, Triggle DJ (1983) New developments in Ca2+ channel antagonists. J Med Chem 26:775–785

    Article  PubMed  CAS  Google Scholar 

  • Klotz V (2002) Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist. Arzneim Forsch/Drug Res 52:155–161

    CAS  Google Scholar 

  • Liang JC, Yeh JL, Chiang LC, Yang YC, Sheu SH, Lai WT, Chen IJ (2000) Labedipinedilol-A: a vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long-lasting antihypertensive properties. Drug Dev Res 49:94–108

    Article  CAS  Google Scholar 

  • Liang JC, Yeh JL, Wang CS, Liou SF, Tsai CH, Chen IJ (2002) The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 10:719–730

    Article  PubMed  CAS  Google Scholar 

  • Mannhold R (1994) Medicinal chemistry of DHP-like calcium antagonist. Drugs Today 30:103–122

    CAS  Google Scholar 

  • Meredith PA (1999) Lercanidipine: a novel lipophilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivity. Expert Opin Investig Drugs 8:1043–1062

    Article  PubMed  CAS  Google Scholar 

  • Perez-Vizcaino F, Carron R, Delphon E, Tamargo J (1993) Effects of (S)-nafenodone on 45 Ca2+ fluxes and contractions in rat isolated vascular smooth muscle. Eur J Pharmacol 232:105–111

    Article  PubMed  CAS  Google Scholar 

  • Ramesh M, Matowe WC, Akula MR, Vo D, Dagnino L, Li-Kwong-Ken MC, Wolowyk MW, Knaus EE (1998) Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl)1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridine-carboxylate racem-ates and enantiomer. J Med Chem 41:509–514

    Article  PubMed  CAS  Google Scholar 

  • Steffen HM (1999) Amlodipine: a third generation dihydropyridine calcium antagonist. J Clin Basic Cardiol 2:45–52

    CAS  Google Scholar 

  • Triggle DJ (2003) 1,4-dihydropyridines as calcium channel ligands and privileged structures. Cell Mol Neurobiol 23:293–303

    Article  PubMed  CAS  Google Scholar 

  • Yeh JL, Liou SF, Liang JC, Huang YC, Chiang LC, Wu JR, Lin YT, Chen IJ (2000) Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities. J Cardiovasc Pharmacol 35:51–63

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are thankful to University Grants Commission, India for providing financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ranju Bansal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bansal, R., Jain, P., Calle, C. et al. Synthesis of a New Series of 4-Aryl-1,4-Dihydropyridines with Calcium Channel Blocking and Vasodilatory Activity. Med Chem Res 21, 908–921 (2012). https://doi.org/10.1007/s00044-011-9600-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-011-9600-x

Keywords

Navigation